Untame的个人主页 - 老虎社区

Untame

Untame

暂无个人介绍

IP属地：未知

144关注

4粉丝

0主题

0勋章

2021-12-27

Nice

Santa Claus Rally watch: What to know this week

2021-12-22

Alright

Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide

2021-12-14

Noted

2 Top Metaverse Stocks to Buy and Hold for the Next Decade

2021-12-14

Noted

Highly valued S&P 500 index is 'near the top of its 85-year trend channel,' says Deutsche Bank

2021-12-09

Keep it coming

Wall St closes higher as vaccine update feeds optimism

2021-12-09

Agree

Wall St closes higher as vaccine update feeds optimism

2021-11-30

Short term gain

5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market

2021-11-30

Nice

4 Stocks Billionaires Are Buying Hand Over Fist

2021-11-30

Downtrend

Stocks open lower as investors assess omicron concerns

2021-11-03

Provided great insight.

@小虎产品经理:Tiger Trade 7.1.2版本来袭，说说你最喜欢哪个功能？

2021-10-28

$20.50Awaiting for financial results to push into $20. Healthy balance sheet and $0.50 dividend next May would be enticing to keep for the next 6 mths.

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3582775076031310,"uuid":"3582775076031310","gmtCreate":1619681241450,"gmtModify":1626693826381,"name":"Untame","pinyin":"untame","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":144,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","exceedPercentage":"80.63%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.76%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":696936634,"gmtCreate":1640594414920,"gmtModify":1640594414992,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696936634","repostId":"2194177239","repostType":4,"repost":{"id":"2194177239","pubTimestamp":1640559609,"share":"https://www.laohu8.com/m/news/2194177239?lang=&edition=full","pubTime":"2021-12-27 07:00","market":"us","language":"en","title":"Santa Claus Rally watch: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177239","media":"Yahoo Finance","summary":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.The S&P 500  is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any ","content":"<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.</p>\n<p>The S&amp;P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.</p>\n<p>The term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.</p>\n<p>According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&amp;P 500 78.9% of the time, with an average return of 1.33%.</p>\n<p>“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”</p>\n<p>And if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.</p>\n<p>\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.</p>\n<p>“Considering the bear markets of 2000 and 2008 both took place after <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"</p>\n<p>And this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.</p>\n<p>\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1279eeacff5d764e6ff5b3e8f7a24f49\" tg-width=\"4000\" tg-height=\"2667\" referrerpolicy=\"no-referrer\"><span>A man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images</span></p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b>Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)</p></li>\n <li><p><b>Tuesday: </b>FHFA House Price Index, month-over-month, October (0.9% in September); S&amp;P <a href=\"https://laohu8.com/S/CLGX\">CoreLogic</a> Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&amp;P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&amp;P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)</p></li>\n <li><p><b>Wednesday: </b>Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)</p></li>\n <li><p><b>Thursday: </b>Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)</p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Wednesday: </b>FuelCell Energy Inc. (FCEL) before market open</p></li>\n <li><p><b>Thursday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Santa Claus Rally watch: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanta Claus Rally watch: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 07:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p>\n\n<a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4541":"氢能源","SPY.AU":"SPDR® S&P 500® ETF Trust","BK4096":"电气部件与设备","FCEL":"燃料电池能源"},"source_url":"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177239","content_text":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.\nThe S&P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.\nThe term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.\nAccording to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&P 500 78.9% of the time, with an average return of 1.33%.\n“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”\nAnd if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.\n\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.\n“Considering the bear markets of 2000 and 2008 both took place after one of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"\nAnd this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.\n\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"\nA man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images\nEconomic calendar\n\nMonday: Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)\nTuesday: FHFA House Price Index, month-over-month, October (0.9% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)\nWednesday: Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)\nThursday: Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)\nFriday: No notable reports scheduled for release\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: FuelCell Energy Inc. (FCEL) before market open\nThursday: No notable reports scheduled for release\nFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691353331,"gmtCreate":1640140258317,"gmtModify":1640140258403,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Alright","listText":"Alright","text":"Alright","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691353331","repostId":"2193663561","repostType":4,"repost":{"id":"2193663561","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640125936,"share":"https://www.laohu8.com/m/news/2193663561?lang=&edition=full","pubTime":"2021-12-22 06:32","market":"us","language":"en","title":"Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2193663561","media":"Reuters","summary":"Dec 21  - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.Gains in massive technology and tech-related stock","content":"<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes up strongly with boost from Nike, Micron, following Omicron slide\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-22 06:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MU":"美光科技","SQQQ":"纳指三倍做空ETF","PSQ":"纳指反向ETF","DXD":"道指两倍做空ETF","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4146":"鞋类","BK4558":"双十一","BK4566":"资本集团","QID":"纳指两倍做空ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","NKE":"耐克","DDM":"道指两倍做多ETF","UDOW":"道指三倍做多ETF-ProShares","BK4561":"索罗斯持仓","SDOW":"道指三倍做空ETF-ProShares","DOG":"道指反向ETF","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","DJX":"1/100道琼斯","TQQQ":"纳指三倍做多ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193663561","content_text":"Energy, tech top-gaining S&P 500 sectors\nTravel stocks surge broadly\nNike up after beating quarterly estimates\nMicron rises as it sees chip shortages easing\nIndexes up: Dow 1.6%, S&P 1.78%, Nasdaq 2.4%\n\nDec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.\nThe rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.\nGains in massive technology and tech-related stocks such as Microsoft and Amazon lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands and Expedia Group.\n“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”\nThe Dow Jones Industrial Average rose 560.54 points, or 1.6%, to 35,492.7, the S&P 500 gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite added 360.14 points, or 2.4%, to 15,341.09.\nDefensive sectors, such as consumer staples and utilities that have led in December, lagged on Tuesday.\nNike shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.\nMicron Technology shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index rose 3.4%.\n“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"\nGeneral Mills shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.\nThe benchmark S&P 500 has gained 23.8% so far in 2021.\nSome investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.\n\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.\nThe S&P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.\nAbout 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607088733,"gmtCreate":1639457971423,"gmtModify":1639458111886,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607088733","repostId":"1174933722","repostType":4,"repost":{"id":"1174933722","pubTimestamp":1639452484,"share":"https://www.laohu8.com/m/news/1174933722?lang=&edition=full","pubTime":"2021-12-14 11:28","market":"us","language":"en","title":"2 Top Metaverse Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=1174933722","media":"Motley Fool","summary":"The metaverse could be the most transformative technology of your lifetime.","content":"<p>The metaverse is a nebulous idea, a technology that's not yet fully defined. But the core concept is simple: The metaverse will be a shared virtual world, blending aspects of social media, video games, and the internet. It will allow people to engage with content, interact with each other, and experience almost anything. The potential implications of that technology are tremendous.</p>\n<p>Venture capitalist Matthew Ball recently put a price tag on the metaverse, estimating that it could be a $30 trillion&nbsp;market opportunity 10 years down the road. And&nbsp;<b>Nvidia</b>&nbsp;CEO Jensen Huang has been even bolder, forecasting that the metaverse economy could eventually surpass the $80 trillion&nbsp;real-world economy.</p>\n<p>Not surprisingly, many investors are looking for ways tocash in on this trend, and buying a few shares of Nvidia and&nbsp;<b>Adobe Systems</b>&nbsp;looks like a great way to do just that.&nbsp;Here's why.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fd705043d0678fb6d8bad5d9d7b0fbef\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p><b>1. Nvidia</b></p>\n<p>Nvidia is best known for inventing the graphics processing unit (GPU), a chip capable of processing a tremendous amount of data quickly. Over the last two decades, GPUs have revolutionized computer graphics, and Nvidia has established its technology as the gold standard in the video game industry. However, those chips have also become the cornerstone of accelerated computing in data centers, another industry&nbsp;dominated by Nvidia.</p>\n<p>Not surprisingly, the chipmaker has made a habit of posting impressive financial results. Revenue soared 64%&nbsp;to $24.3 billion over the past year, supercharged by Nvidia's gaming, data center, and graphics businesses. Its bottom line grew even faster, as&nbsp;free cash flow&nbsp;rocketed 69% to $7.2 billion.</p>\n<p>In the coming years, Nvidia's expertise in graphics and accelerated computing should make it a key player in shaping the metaverse. Its recent launch of the Omniverse suite only makes that more likely. Specifically, Omniverse is a GPU-powered 3D development platform that allows creators to collaborate in real time across a variety of 3D design software. That includes products like&nbsp;<b>Unity</b>'s&nbsp;game engine&nbsp;and Adobe Substance 3D.</p>\n<p>More recently, Nvidia released Omniverse Avatar, a platform for creating artifical-intelligence-powered avatars (digital automatons) that can think, understand, and interact like real people. That's important because the metaverse will likely be full of non-player characters (NPCs), a term that typically refers to video game characters not controlled by the gamer. Those NPCs will make the metaverse feel more like the real world, and Nvidia's technology looks like a perfect fit.</p>\n<p><b>2. Adobe Systems</b></p>\n<p>Adobe breaks its portfolio into three software clouds: Creativity, digital documents, and customer experience. Creative Cloud is perhaps the best known, featuring tools like Photoshop&nbsp;for image editing, Premiere Pro&nbsp;for video editing, and After Effects for cinematic special effects, all three of which are market-leading products. Likewise, many of Adobe's Document Cloud applications have also become industry standards, such as Acrobat for PDF management.</p>\n<p>The other piece of Adobe's business is Experience Cloud, a suite of software and services for analytics, marketing, and commerce. Those tools lean on&nbsp;artificial intelligence&nbsp;to help businesses collect data, target content, and personalize the customer journey across mobile apps, websites, and other digital channels. Research company&nbsp;<b>Gartner</b>&nbsp;has recognized Adobe as a leader in the digital experience industry, citing its capacity to manage customer data and personalize content as key differentiators.</p>\n<p>Not surprisingly, Adobe's lineup of best-in-class products has been a powerful growth driver. Over the past year, revenue rose 21% to $15.1 billion, and free cash flow surged 34% to $6.6 billion. Moreover, the company is well positioned to maintain that momentum, as many products in its portfolio are relevant to the metaverse, especially in the Creative Cloud and Experience Cloud suites.</p>\n<p>For instance, Adobe Substance&nbsp;3D is a platform for creating, staging, and texturizing 3D content. Substance 3D is already essential&nbsp;to most video game and visual effects workflows, and it should be a valuable resource in creating the virtual content within the metaverse.</p>\n<p>Likewise, the metaverse economy will likely mirror the real-world economy, meaning consumers will be able to shop, attend events, and play games. In other words, providing a high-quality experience will be just as critical in a virtual world as it is in the real world. And Adobe's tools for analytics, marketing, and commerce fit that bill perfectly.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Metaverse Stocks to Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Metaverse Stocks to Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 11:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/13/2-top-metaverse-stocks-to-buy-and-hold/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The metaverse is a nebulous idea, a technology that's not yet fully defined. But the core concept is simple: The metaverse will be a shared virtual world, blending aspects of social media, video games...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/13/2-top-metaverse-stocks-to-buy-and-hold/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","ADBE":"Adobe"},"source_url":"https://www.fool.com/investing/2021/12/13/2-top-metaverse-stocks-to-buy-and-hold/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174933722","content_text":"The metaverse is a nebulous idea, a technology that's not yet fully defined. But the core concept is simple: The metaverse will be a shared virtual world, blending aspects of social media, video games, and the internet. It will allow people to engage with content, interact with each other, and experience almost anything. The potential implications of that technology are tremendous.\nVenture capitalist Matthew Ball recently put a price tag on the metaverse, estimating that it could be a $30 trillion market opportunity 10 years down the road. And Nvidia CEO Jensen Huang has been even bolder, forecasting that the metaverse economy could eventually surpass the $80 trillion real-world economy.\nNot surprisingly, many investors are looking for ways tocash in on this trend, and buying a few shares of Nvidia and Adobe Systems looks like a great way to do just that. Here's why.\nImage source: Getty Images.\n1. Nvidia\nNvidia is best known for inventing the graphics processing unit (GPU), a chip capable of processing a tremendous amount of data quickly. Over the last two decades, GPUs have revolutionized computer graphics, and Nvidia has established its technology as the gold standard in the video game industry. However, those chips have also become the cornerstone of accelerated computing in data centers, another industry dominated by Nvidia.\nNot surprisingly, the chipmaker has made a habit of posting impressive financial results. Revenue soared 64% to $24.3 billion over the past year, supercharged by Nvidia's gaming, data center, and graphics businesses. Its bottom line grew even faster, as free cash flow rocketed 69% to $7.2 billion.\nIn the coming years, Nvidia's expertise in graphics and accelerated computing should make it a key player in shaping the metaverse. Its recent launch of the Omniverse suite only makes that more likely. Specifically, Omniverse is a GPU-powered 3D development platform that allows creators to collaborate in real time across a variety of 3D design software. That includes products like Unity's game engine and Adobe Substance 3D.\nMore recently, Nvidia released Omniverse Avatar, a platform for creating artifical-intelligence-powered avatars (digital automatons) that can think, understand, and interact like real people. That's important because the metaverse will likely be full of non-player characters (NPCs), a term that typically refers to video game characters not controlled by the gamer. Those NPCs will make the metaverse feel more like the real world, and Nvidia's technology looks like a perfect fit.\n2. Adobe Systems\nAdobe breaks its portfolio into three software clouds: Creativity, digital documents, and customer experience. Creative Cloud is perhaps the best known, featuring tools like Photoshop for image editing, Premiere Pro for video editing, and After Effects for cinematic special effects, all three of which are market-leading products. Likewise, many of Adobe's Document Cloud applications have also become industry standards, such as Acrobat for PDF management.\nThe other piece of Adobe's business is Experience Cloud, a suite of software and services for analytics, marketing, and commerce. Those tools lean on artificial intelligence to help businesses collect data, target content, and personalize the customer journey across mobile apps, websites, and other digital channels. Research company Gartner has recognized Adobe as a leader in the digital experience industry, citing its capacity to manage customer data and personalize content as key differentiators.\nNot surprisingly, Adobe's lineup of best-in-class products has been a powerful growth driver. Over the past year, revenue rose 21% to $15.1 billion, and free cash flow surged 34% to $6.6 billion. Moreover, the company is well positioned to maintain that momentum, as many products in its portfolio are relevant to the metaverse, especially in the Creative Cloud and Experience Cloud suites.\nFor instance, Adobe Substance 3D is a platform for creating, staging, and texturizing 3D content. Substance 3D is already essential to most video game and visual effects workflows, and it should be a valuable resource in creating the virtual content within the metaverse.\nLikewise, the metaverse economy will likely mirror the real-world economy, meaning consumers will be able to shop, attend events, and play games. In other words, providing a high-quality experience will be just as critical in a virtual world as it is in the real world. And Adobe's tools for analytics, marketing, and commerce fit that bill perfectly.","news_type":1},"isVote":1,"tweetType":1,"viewCount":502,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607081466,"gmtCreate":1639457813749,"gmtModify":1639457813749,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607081466","repostId":"2191841329","repostType":4,"repost":{"id":"2191841329","pubTimestamp":1639452680,"share":"https://www.laohu8.com/m/news/2191841329?lang=&edition=full","pubTime":"2021-12-14 11:31","market":"us","language":"en","title":"Highly valued S&P 500 index is 'near the top of its 85-year trend channel,' says Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2191841329","media":"MarketWatch","summary":"'Inflation has historically been neutral for earnings, but negative for multiples,' says a Deutsche ","content":"<p>'Inflation has historically been neutral for earnings, but negative for multiples,' says a Deutsche Bank report</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7b7803ce34d9ebaddbf2c083be3d67a2\" tg-width=\"700\" tg-height=\"458\" referrerpolicy=\"no-referrer\"><span>The S&amp;P 500 index closed at a record high on Dec. 10, 2021. Chris Hondros/Getty Images</span></p>\n<p>The S&amp;P 500's \"extremely high\" historical valuation puts the index near the upper bound of a \"trend channel of price appreciation\" that spans more than eight decades, but the broad equity benchmark still could go higher, according to Deutsche Bank Research.</p>\n<p>The U.S. stock index is \"near the top of its 85-year trend channel,\" the bank's strategists wrote in a research report dated Dec. 10. \"It was only higher in the late 1930s and late 1990s, when it went above,\" a chart in the report shows.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4d4fc2a69934ea51cf28c489fdfd23d4\" tg-width=\"700\" tg-height=\"423\" referrerpolicy=\"no-referrer\"><span>DEUTSCHE BANK RESEARCH REPORT DATED DEC. 10, 2021</span></p>\n<p>The S&amp;P 500 closed Dec. 10 at a record high of 4,712.02 and is on track to gain more than 24% this year, according to FactSet data.</p>\n<p>Deutsche Bank's strategists project the index will continue to climb next year, pointing to earnings growth and saying in their report that stock buybacks should help keep S&amp;P 500 returns strong, particularly in the first half of 2022. They have a price target of 5,250 for the S&amp;P 500 by the end of next year, according to their research note.</p>\n<p>Deutsche Bank Research is part of the investment banking division. Separately, the chief investment office of the bank's wealth-management division provided a 2022 outlook presentation on Dec. 6 that showed an S&amp;P 500 target of 5,000.</p>\n<p>\"For the S&amp;P 500, we see 10% earnings growth to $230 in 2022,\" according to the Deutsche Bank Research note dated Dec. 10, with the strategists referring to their earnings-per-share forecast.</p>\n<p>\"Inflation has historically been neutral for earnings, but negative for multiples,\" they wrote, against the backdrop of a surge in the cost of living during the pandemic.</p>\n<p>Valuations for the S&amp;P 500 index are \"extremely high,\" according to the Deutsche Bank Research report. \"Equity valuations are in the 97-100th percentile on almost any metric excluding the 1990s tech bubble period and well into the 90s in percentile terms even including it,\" the strategists wrote.</p>\n<p>Their 2022 forecast for the S&amp;P 500 implies a trailing 12-month price-to earnings ratio of 22.8, the research report from Dec. 10 shows.</p>\n<p>\"With earnings having already recovered to levels above trend that often marked cycle peaks and equity valuations historically high, the outlook for equities looks subject to a larger degree of uncertainty and a wider range of possible outcomes than is typical,\" the strategists cautioned.</p>\n<p>U.S. stock indexes closed lower Monday, with S&amp;P 500 ending 0.9% lower, FactSet data show.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Highly valued S&P 500 index is 'near the top of its 85-year trend channel,' says Deutsche Bank</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHighly valued S&P 500 index is 'near the top of its 85-year trend channel,' says Deutsche Bank\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 11:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/highly-valued-s-p-500-index-is-near-the-top-of-its-85-year-trend-channel-says-deutsche-bank-11639432105?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>'Inflation has historically been neutral for earnings, but negative for multiples,' says a Deutsche Bank report\nThe S&P 500 index closed at a record high on Dec. 10, 2021. Chris Hondros/Getty Images\n...</p>\n\n<a href=\"https://www.marketwatch.com/story/highly-valued-s-p-500-index-is-near-the-top-of-its-85-year-trend-channel-says-deutsche-bank-11639432105?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","OEX":"标普100","SSO":"两倍做多标普500ETF","BK4534":"瑞士信贷持仓","SPXU":"三倍做空标普500ETF","BK4566":"资本集团","OEF":"标普100指数ETF-iShares","SPY":"标普500ETF","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","DB":"德意志银行",".IXIC":"NASDAQ Composite","BK4552":"Archegos爆仓风波概念","BK4118":"综合性资本市场","IVV":"标普500指数ETF","UPRO":"三倍做多标普500ETF","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF",".DJI":"道琼斯","SH":"标普500反向ETF"},"source_url":"https://www.marketwatch.com/story/highly-valued-s-p-500-index-is-near-the-top-of-its-85-year-trend-channel-says-deutsche-bank-11639432105?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191841329","content_text":"'Inflation has historically been neutral for earnings, but negative for multiples,' says a Deutsche Bank report\nThe S&P 500 index closed at a record high on Dec. 10, 2021. Chris Hondros/Getty Images\nThe S&P 500's \"extremely high\" historical valuation puts the index near the upper bound of a \"trend channel of price appreciation\" that spans more than eight decades, but the broad equity benchmark still could go higher, according to Deutsche Bank Research.\nThe U.S. stock index is \"near the top of its 85-year trend channel,\" the bank's strategists wrote in a research report dated Dec. 10. \"It was only higher in the late 1930s and late 1990s, when it went above,\" a chart in the report shows.\nDEUTSCHE BANK RESEARCH REPORT DATED DEC. 10, 2021\nThe S&P 500 closed Dec. 10 at a record high of 4,712.02 and is on track to gain more than 24% this year, according to FactSet data.\nDeutsche Bank's strategists project the index will continue to climb next year, pointing to earnings growth and saying in their report that stock buybacks should help keep S&P 500 returns strong, particularly in the first half of 2022. They have a price target of 5,250 for the S&P 500 by the end of next year, according to their research note.\nDeutsche Bank Research is part of the investment banking division. Separately, the chief investment office of the bank's wealth-management division provided a 2022 outlook presentation on Dec. 6 that showed an S&P 500 target of 5,000.\n\"For the S&P 500, we see 10% earnings growth to $230 in 2022,\" according to the Deutsche Bank Research note dated Dec. 10, with the strategists referring to their earnings-per-share forecast.\n\"Inflation has historically been neutral for earnings, but negative for multiples,\" they wrote, against the backdrop of a surge in the cost of living during the pandemic.\nValuations for the S&P 500 index are \"extremely high,\" according to the Deutsche Bank Research report. \"Equity valuations are in the 97-100th percentile on almost any metric excluding the 1990s tech bubble period and well into the 90s in percentile terms even including it,\" the strategists wrote.\nTheir 2022 forecast for the S&P 500 implies a trailing 12-month price-to earnings ratio of 22.8, the research report from Dec. 10 shows.\n\"With earnings having already recovered to levels above trend that often marked cycle peaks and equity valuations historically high, the outlook for equities looks subject to a larger degree of uncertainty and a wider range of possible outcomes than is typical,\" the strategists cautioned.\nU.S. stock indexes closed lower Monday, with S&P 500 ending 0.9% lower, FactSet data show.","news_type":1},"isVote":1,"tweetType":1,"viewCount":689,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602622932,"gmtCreate":1639017160657,"gmtModify":1639017160657,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keep it coming","listText":"Keep it coming","text":"Keep it coming","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602622932","repostId":"2190169579","repostType":4,"repost":{"id":"2190169579","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639001174,"share":"https://www.laohu8.com/m/news/2190169579?lang=&edition=full","pubTime":"2021-12-09 06:06","market":"us","language":"en","title":"Wall St closes higher as vaccine update feeds optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2190169579","media":"Reuters","summary":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st","content":"<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes higher as vaccine update feeds optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes higher as vaccine update feeds optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 06:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","TQQQ":"纳指三倍做多ETF","SWK":"美国史丹利公司","PFE":"辉瑞","BK4007":"制药","BK4566":"资本集团","SQQQ":"纳指三倍做空ETF","DXD":"道指两倍做空ETF","NCLH":"挪威邮轮","PSQ":"纳指反向ETF","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓",".DJI":"道琼斯","BK4517":"邮轮概念",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","QID":"纳指两倍做空ETF","CCL":"嘉年华邮轮","DDM":"道指两倍做多ETF","BK4142":"酒店、度假村与豪华游轮","QQQ":"纳指100ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","UDOW":"道指三倍做多ETF-ProShares","SDOW":"道指三倍做空ETF-ProShares","QLD":"纳指两倍做多ETF","BK4161":"工业机械","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190169579","content_text":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.\nPfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.\nInvestors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.\nMarkets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.\nIn a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.\nWhile Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.\nWith Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"\n\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.\nThe Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.\nThe S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.\n\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.\nSector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.\nWHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.\nSo-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.\nGoodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".\nStanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.\nOn U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":754,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602628726,"gmtCreate":1639017058007,"gmtModify":1639017058077,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Agree","listText":"Agree","text":"Agree","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602628726","repostId":"2190169579","repostType":4,"repost":{"id":"2190169579","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639001174,"share":"https://www.laohu8.com/m/news/2190169579?lang=&edition=full","pubTime":"2021-12-09 06:06","market":"us","language":"en","title":"Wall St closes higher as vaccine update feeds optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2190169579","media":"Reuters","summary":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st","content":"<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes higher as vaccine update feeds optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes higher as vaccine update feeds optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 06:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","TQQQ":"纳指三倍做多ETF","SWK":"美国史丹利公司","PFE":"辉瑞","BK4007":"制药","BK4566":"资本集团","SQQQ":"纳指三倍做空ETF","DXD":"道指两倍做空ETF","NCLH":"挪威邮轮","PSQ":"纳指反向ETF","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓",".DJI":"道琼斯","BK4517":"邮轮概念",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","QID":"纳指两倍做空ETF","CCL":"嘉年华邮轮","DDM":"道指两倍做多ETF","BK4142":"酒店、度假村与豪华游轮","QQQ":"纳指100ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","UDOW":"道指三倍做多ETF-ProShares","SDOW":"道指三倍做空ETF-ProShares","QLD":"纳指两倍做多ETF","BK4161":"工业机械","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190169579","content_text":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.\nPfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.\nInvestors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.\nMarkets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.\nIn a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.\nWhile Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.\nWith Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"\n\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.\nThe Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.\nThe S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.\n\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.\nSector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.\nWHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.\nSo-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.\nGoodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".\nStanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.\nOn U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609267310,"gmtCreate":1638286937173,"gmtModify":1638286937173,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Short term gain","listText":"Short term gain","text":"Short term gain","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609267310","repostId":"1190156196","repostType":4,"repost":{"id":"1190156196","pubTimestamp":1638242388,"share":"https://www.laohu8.com/m/news/1190156196?lang=&edition=full","pubTime":"2021-11-30 11:19","market":"us","language":"en","title":"5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190156196","media":"InvestorPlace","summary":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race","content":"<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/537aabc5fd6c7ca4f614ce1b37dc0a75\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Shutterstock</span></p>\n<p>As Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?</p>\n<p>Investors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.</p>\n<p>While&nbsp;<b>Pfizer’s</b>(NYSE:<b><u>PFE</u></b>)&nbsp;success in&nbsp;producing&nbsp;a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.</p>\n<p>Many vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.</p>\n<ul>\n <li><b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>)</li>\n <li><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>)</li>\n <li><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>)</li>\n <li><b>Johnson &amp; Johnson</b>(NYSE:<b><u>JNJ</u></b>)</li>\n <li><b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>)</li>\n</ul>\n<p><b>Moderna (MRNA)</b></p>\n<p>Moderna was one of the first companies to have its executive team discuss address the omicron variant.</p>\n<p>On Sunday, CMO Paul Burton spoke to<i>BBC’s</i>Andrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketo<i>CNBC’s</i>“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.</p>\n<p>Bancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.</p>\n<p>This talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.</p>\n<p>While&nbsp;the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p><b>Pfizer (PFE)</b></p>\n<p>No pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one&nbsp;<i>InvestorPlace</i>&nbsp;contributorfor CEO of the year.</p>\n<p>The industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.</p>\n<p>Clinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.</p>\n<p>While Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.</p>\n<p>It is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.</p>\n<p><b>BioNTech (BNTX)</b></p>\n<p>Pfizer’s original vaccine partner isn’t missing a beat, either.</p>\n<p>The German biotech innovatortold<i>Business Insider</i>that it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.</p>\n<p>Like its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.</p>\n<p>Like other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,<i>InvestorPlace</i>&nbsp;analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.</p>\n<p><b>Johnson &amp; Johnson (JNJ)</b></p>\n<p>Like its competitors, Johnson &amp; Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”</p>\n<p>Mathai Mammen, global head of research and development at J&amp;J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.</p>\n<p>Mammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.</p>\n<p><b>Novavax (NVAX)</b></p>\n<p>A later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.</p>\n<p>However, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”</p>\n<p>While Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.</p>\n<p>As&nbsp;<i>InvestorPlace</i>&nbsp;Assistant News Writer&nbsp;Eddie Pan&nbsp;reported&nbsp;this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis ...</p>\n\n<a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","JNJ":"强生"},"source_url":"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190156196","content_text":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?\nInvestors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.\nWhile Pfizer’s(NYSE:PFE) success in producing a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.\nMany vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.\n\nModerna(NASDAQ:MRNA)\nPfizer(NYSE:PFE)\nBioNTech (NASDAQ:BNTX)\nJohnson & Johnson(NYSE:JNJ)\nNovavax(NASDAQ:NVAX)\n\nModerna (MRNA)\nModerna was one of the first companies to have its executive team discuss address the omicron variant.\nOn Sunday, CMO Paul Burton spoke toBBC’sAndrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketoCNBC’s“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.\nBancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.\nThis talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.\nWhile the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nPfizer (PFE)\nNo pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one InvestorPlace contributorfor CEO of the year.\nThe industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.\nClinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.\nWhile Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.\nIt is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.\nBioNTech (BNTX)\nPfizer’s original vaccine partner isn’t missing a beat, either.\nThe German biotech innovatortoldBusiness Insiderthat it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.\nLike its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.\nLike other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,InvestorPlace analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.\nJohnson & Johnson (JNJ)\nLike its competitors, Johnson & Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”\nMathai Mammen, global head of research and development at J&J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.\nMammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.\nNovavax (NVAX)\nA later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.\nHowever, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”\nWhile Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.\nAs InvestorPlace Assistant News Writer Eddie Pan reported this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609264096,"gmtCreate":1638286871807,"gmtModify":1638286871807,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609264096","repostId":"2187817235","repostType":4,"repost":{"id":"2187817235","pubTimestamp":1638279553,"share":"https://www.laohu8.com/m/news/2187817235?lang=&edition=full","pubTime":"2021-11-30 21:39","market":"us","language":"en","title":"4 Stocks Billionaires Are Buying Hand Over Fist","url":"https://stock-news.laohu8.com/highlight/detail?id=2187817235","media":"Motley Fool","summary":"Successful money managers purchased a number of unexpected stocks in the third quarter.","content":"<p>You may not realize it, but one of the most important data releases of the quarter occurred approximately two weeks ago.</p>\n<p>On Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). A 13F provides Wall Street and investors with an under-the-hood look at what the smartest money managers were buying and selling in the previous quarter (i.e., the third quarter). Though 13Fs are a bit dated by the time they're filed with the SEC (holdings are as of Sept. 30, 2021), they still provide valuable clues of what's catching the attention of the world's most successful fund managers.</p>\n<p>With the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. However, they didn't necessarily buy the names you'd expect.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F654909%2Fbusinessman-looking-at-ticker-board-stock-market-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Ken Griffin (Citadel Advisors): Tesla Motors</h2>\n<p>Billionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions. But the big story from the third quarter is that Citadel made electric vehicle (EV) manufacturer <b>Tesla Motors</b> (NASDAQ:TSLA) its largest non-options holding. Griffin's fund bought close to 1.8 million shares of Tesla in the third quarter, increasing its position by 873% from the end of June.</p>\n<p>Why Tesla? One logical explanation is that EVs are inevitable. Pretty much every major economic powerhouse worldwide is focused on reducing carbon emissions going forward. Perhaps the easiest way to make a dent in carbon emissions is to push a multi-decade vehicle replacement cycle.</p>\n<p>A more likely explanation for Griffin's interest in Tesla is the company's first-mover advantage. Even with an ongoing semiconductor chip shortage, Tesla looks to be on pace to hit 800,000 (or more) EV deliveries in 2021. Further, it could reasonably pace 50% annual delivery growth over the next couple of years as new gigafactories come online. With no other automakers coming close (at the moment) to its combination of battery range, power, and capacity, Griffin likely feels he and his fund can ride this momentum higher.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F654909%2Fko-drink-bottle.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"><span>Image source: Coca-Cola.</span></p>\n<h2>Jim Simons (Renaissance Technologies): Coca-Cola</h2>\n<p>For a highly diversified fund known for its love of innovation, the shock of the quarter might just be that billionaire Jim Simons was buying beverage giant <b>Coca-Cola</b> (NYSE:KO) hand over fist. All told, Renaissance Technologies added a little over 6 million shares of Coke in the third quarter, which more than tripled its stake as of the end of June.</p>\n<p>With the benchmark <b>S&amp;P 500</b> taking less than 17 months to double from its coronavirus bear-market bottom, Simons' substantially increased stake in Coke might be a means of playing it safe and hedging his funds' bets. Since Coca-Cola has a presence in all but two countries worldwide (Cuba and North Korea), and its portfolio sports more than 20 brands generating at least $1 billion in annual sales, it's a safe bet to generate modest returns -- or at worst hold up much better than the broader market if a crash or correction strikes.</p>\n<p>Coca-Cola is also a relatively smart inflation play. The company is parsing out a hearty 3.1% yield, has raised its base annual dividend for 59 consecutive years, and its well-known brand makes it easy for the company to pass along higher costs to its customers.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F654909%2Fmature-woman-shopping-mall-retail-gdp-clothing-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>David Tepper (Appaloosa): Macy's</h2>\n<p>In a market dominated by growth stocks, billionaire David Tepper headed to the retail counter in the third quarter and piled into department store <b>Macy's</b> (NYSE:M). Tepper's Appaloosa purchased 3.39 million shares, which lifted the fund's stake to an even 7 million shares.</p>\n<p>Scratching your head as to why a successful money manager is buying into an old-school retailer? The answer looks to be Macy's, thus far, solid execution on its three-year Polaris strategy. In no particular order, this strategy includes:</p>\n<ul>\n <li>Closing underperforming stores and reducing corporate and store-level staff to cut expenses.</li>\n <li>Emphasizing digital sales channels, which are a high-growth opportunity for the company until the pandemic ends (and perhaps well after).</li>\n <li>Increasing customer engagement through its loyalty rewards program.</li>\n <li>Focusing its efforts of a small number of higher-margin private brands.</li>\n</ul>\n<p>Although Macy's has challenges to overcome, such as continuing to pay down more than $6 billion in debt, the initial results show its digitization and branding efforts are paying off. The company ended September with 4.4 million new customers, up 28% from the comparable period in 2019 (i.e., before the pandemic). Additionally, 33% of net sales derived online, up from 23% in Q3 2019.&nbsp; If these arrows continue to point higher, Tepper may have found himself a bargain.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F654909%2Fwoman-talk-smartphone-city-wireless-5g-4g-data-voicemail-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Israel Englander (Millennium Management): AT&amp;T</h2>\n<p>Like Ken Griffin, billionaire Israel Englander is a big fan of utilizing put and call options to maximize returns for his fund, Millennium Management. However, the big buy in the third quarter was stodgy telecom giant <b>AT&amp;T</b> (NYSE:T). Englander's fund bought up close to 11.2 million shares, which increased its stake by 165% from the sequential second quarter.</p>\n<p>Similar to Coca-Cola, buying AT&amp;T is a play on value and stability in a very pricey market. For the time being, it's paying out an inflation-topping 8.6% yield and can be purchased for a little north of 7 times Wall Street's estimated earnings per share this year.</p>\n<p>But what might have wet Englander's whistle is AT&amp;T's plan to spin off its content arm, WarnerMedia, and combine it with <b>Discovery</b>. Combining forces will save more than $3 billion in annual costs and vastly improve original and sports programming options for streaming customers. Most importantly, it'll allow AT&amp;T to reduce its debt (and its dividend, as well) and focus on growing its wireless business with the ongoing rollout of 5G infrastructure.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Billionaires Are Buying Hand Over Fist</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Billionaires Are Buying Hand Over Fist\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/30/4-stocks-billionaires-are-buying-hand-over-fist/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You may not realize it, but one of the most important data releases of the quarter occurred approximately two weeks ago.\nOn Nov. 15, institutional investors and hedge funds with at least $100 million ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/30/4-stocks-billionaires-are-buying-hand-over-fist/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","BK4548":"巴美列捷福持仓","EV":"MAST GLOBAL BATTERY RECYCLING & PRODUCTION ETF","T":"美国电话电报","KO":"可口可乐","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4177":"软饮料","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","M":"梅西百货","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","BK4115":"综合电信业务","BK4551":"寇图资本持仓","BK4103":"百货商店","BK4504":"桥水持仓","BK4099":"汽车制造商"},"source_url":"https://www.fool.com/investing/2021/11/30/4-stocks-billionaires-are-buying-hand-over-fist/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187817235","content_text":"You may not realize it, but one of the most important data releases of the quarter occurred approximately two weeks ago.\nOn Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). A 13F provides Wall Street and investors with an under-the-hood look at what the smartest money managers were buying and selling in the previous quarter (i.e., the third quarter). Though 13Fs are a bit dated by the time they're filed with the SEC (holdings are as of Sept. 30, 2021), they still provide valuable clues of what's catching the attention of the world's most successful fund managers.\nWith the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. However, they didn't necessarily buy the names you'd expect.\nImage source: Getty Images.\nKen Griffin (Citadel Advisors): Tesla Motors\nBillionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions. But the big story from the third quarter is that Citadel made electric vehicle (EV) manufacturer Tesla Motors (NASDAQ:TSLA) its largest non-options holding. Griffin's fund bought close to 1.8 million shares of Tesla in the third quarter, increasing its position by 873% from the end of June.\nWhy Tesla? One logical explanation is that EVs are inevitable. Pretty much every major economic powerhouse worldwide is focused on reducing carbon emissions going forward. Perhaps the easiest way to make a dent in carbon emissions is to push a multi-decade vehicle replacement cycle.\nA more likely explanation for Griffin's interest in Tesla is the company's first-mover advantage. Even with an ongoing semiconductor chip shortage, Tesla looks to be on pace to hit 800,000 (or more) EV deliveries in 2021. Further, it could reasonably pace 50% annual delivery growth over the next couple of years as new gigafactories come online. With no other automakers coming close (at the moment) to its combination of battery range, power, and capacity, Griffin likely feels he and his fund can ride this momentum higher.\nImage source: Coca-Cola.\nJim Simons (Renaissance Technologies): Coca-Cola\nFor a highly diversified fund known for its love of innovation, the shock of the quarter might just be that billionaire Jim Simons was buying beverage giant Coca-Cola (NYSE:KO) hand over fist. All told, Renaissance Technologies added a little over 6 million shares of Coke in the third quarter, which more than tripled its stake as of the end of June.\nWith the benchmark S&P 500 taking less than 17 months to double from its coronavirus bear-market bottom, Simons' substantially increased stake in Coke might be a means of playing it safe and hedging his funds' bets. Since Coca-Cola has a presence in all but two countries worldwide (Cuba and North Korea), and its portfolio sports more than 20 brands generating at least $1 billion in annual sales, it's a safe bet to generate modest returns -- or at worst hold up much better than the broader market if a crash or correction strikes.\nCoca-Cola is also a relatively smart inflation play. The company is parsing out a hearty 3.1% yield, has raised its base annual dividend for 59 consecutive years, and its well-known brand makes it easy for the company to pass along higher costs to its customers.\nImage source: Getty Images.\nDavid Tepper (Appaloosa): Macy's\nIn a market dominated by growth stocks, billionaire David Tepper headed to the retail counter in the third quarter and piled into department store Macy's (NYSE:M). Tepper's Appaloosa purchased 3.39 million shares, which lifted the fund's stake to an even 7 million shares.\nScratching your head as to why a successful money manager is buying into an old-school retailer? The answer looks to be Macy's, thus far, solid execution on its three-year Polaris strategy. In no particular order, this strategy includes:\n\nClosing underperforming stores and reducing corporate and store-level staff to cut expenses.\nEmphasizing digital sales channels, which are a high-growth opportunity for the company until the pandemic ends (and perhaps well after).\nIncreasing customer engagement through its loyalty rewards program.\nFocusing its efforts of a small number of higher-margin private brands.\n\nAlthough Macy's has challenges to overcome, such as continuing to pay down more than $6 billion in debt, the initial results show its digitization and branding efforts are paying off. The company ended September with 4.4 million new customers, up 28% from the comparable period in 2019 (i.e., before the pandemic). Additionally, 33% of net sales derived online, up from 23% in Q3 2019.  If these arrows continue to point higher, Tepper may have found himself a bargain.\nImage source: Getty Images.\nIsrael Englander (Millennium Management): AT&T\nLike Ken Griffin, billionaire Israel Englander is a big fan of utilizing put and call options to maximize returns for his fund, Millennium Management. However, the big buy in the third quarter was stodgy telecom giant AT&T (NYSE:T). Englander's fund bought up close to 11.2 million shares, which increased its stake by 165% from the sequential second quarter.\nSimilar to Coca-Cola, buying AT&T is a play on value and stability in a very pricey market. For the time being, it's paying out an inflation-topping 8.6% yield and can be purchased for a little north of 7 times Wall Street's estimated earnings per share this year.\nBut what might have wet Englander's whistle is AT&T's plan to spin off its content arm, WarnerMedia, and combine it with Discovery. Combining forces will save more than $3 billion in annual costs and vastly improve original and sports programming options for streaming customers. Most importantly, it'll allow AT&T to reduce its debt (and its dividend, as well) and focus on growing its wireless business with the ongoing rollout of 5G infrastructure.","news_type":1},"isVote":1,"tweetType":1,"viewCount":571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609672054,"gmtCreate":1638283492985,"gmtModify":1638283492985,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Downtrend","listText":"Downtrend","text":"Downtrend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609672054","repostId":"1167187587","repostType":4,"repost":{"id":"1167187587","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638282732,"share":"https://www.laohu8.com/m/news/1167187587?lang=&edition=full","pubTime":"2021-11-30 22:32","market":"us","language":"en","title":"Stocks open lower as investors assess omicron concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1167187587","media":"Tiger Newspress","summary":"Stocks tumbled on Tuesday, reversing Monday's rebound on Wall Street, as investors reassessed risks ","content":"<p>Stocks tumbled on Tuesday, reversing Monday's rebound on Wall Street, as investors reassessed risks associated with the new omicron Covid variant.</p>\n<p>The Dow Jones Industrial Average dropped about 290 points, or 0.8%. The S&amp;P 500 shed 0.64%. The technology-heavy Nasdaq Composite shed about 0.4%. The small-cap benchmark Russell 2000 dropped 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/078050fb74fa44676c309ee766ee815d\" tg-width=\"1080\" tg-height=\"472\" referrerpolicy=\"no-referrer\"></p>\n<p>Tuesday's reversal came after&nbsp;Moderna&nbsp;CEO Stephane Bancel told the Financial Times that he&nbsp;expects existing vaccines to be less effective&nbsp;against the new variant. The CEO told the paper there could be a \"material drop\" in the current vaccines' effectiveness against this variant. Bancel told CNBC on Monday that it could take&nbsp;months to develop and ship an omicron-specific vaccine. Moderna was down nearly 4%.</p>\n<p>Separately,Regeneron&nbsp;said its antibody treatment may have reduced effectiveness against omicron. Regeneron shares lost about 1%.</p>\n<p>Travel shares, which led Friday's drop and then gained on Monday, were taking hits once again Tuesday.Expedia Group&nbsp;fell 2%,Norwegian Cruise Line Holdings&nbsp;and&nbsp;American Airlines&nbsp;&nbsp;shares&nbsp;tumbled about&nbsp;2%.</p>\n<p>Bucking the broader market's trend, stay-at-home stock Netflix rose 1.4% and Tesla gained 1.5%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks open lower as investors assess omicron concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks open lower as investors assess omicron concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-30 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks tumbled on Tuesday, reversing Monday's rebound on Wall Street, as investors reassessed risks associated with the new omicron Covid variant.</p>\n<p>The Dow Jones Industrial Average dropped about 290 points, or 0.8%. The S&amp;P 500 shed 0.64%. The technology-heavy Nasdaq Composite shed about 0.4%. The small-cap benchmark Russell 2000 dropped 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/078050fb74fa44676c309ee766ee815d\" tg-width=\"1080\" tg-height=\"472\" referrerpolicy=\"no-referrer\"></p>\n<p>Tuesday's reversal came after&nbsp;Moderna&nbsp;CEO Stephane Bancel told the Financial Times that he&nbsp;expects existing vaccines to be less effective&nbsp;against the new variant. The CEO told the paper there could be a \"material drop\" in the current vaccines' effectiveness against this variant. Bancel told CNBC on Monday that it could take&nbsp;months to develop and ship an omicron-specific vaccine. Moderna was down nearly 4%.</p>\n<p>Separately,Regeneron&nbsp;said its antibody treatment may have reduced effectiveness against omicron. Regeneron shares lost about 1%.</p>\n<p>Travel shares, which led Friday's drop and then gained on Monday, were taking hits once again Tuesday.Expedia Group&nbsp;fell 2%,Norwegian Cruise Line Holdings&nbsp;and&nbsp;American Airlines&nbsp;&nbsp;shares&nbsp;tumbled about&nbsp;2%.</p>\n<p>Bucking the broader market's trend, stay-at-home stock Netflix rose 1.4% and Tesla gained 1.5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167187587","content_text":"Stocks tumbled on Tuesday, reversing Monday's rebound on Wall Street, as investors reassessed risks associated with the new omicron Covid variant.\nThe Dow Jones Industrial Average dropped about 290 points, or 0.8%. The S&P 500 shed 0.64%. The technology-heavy Nasdaq Composite shed about 0.4%. The small-cap benchmark Russell 2000 dropped 0.7%.\n\nTuesday's reversal came after Moderna CEO Stephane Bancel told the Financial Times that he expects existing vaccines to be less effective against the new variant. The CEO told the paper there could be a \"material drop\" in the current vaccines' effectiveness against this variant. Bancel told CNBC on Monday that it could take months to develop and ship an omicron-specific vaccine. Moderna was down nearly 4%.\nSeparately,Regeneron said its antibody treatment may have reduced effectiveness against omicron. Regeneron shares lost about 1%.\nTravel shares, which led Friday's drop and then gained on Monday, were taking hits once again Tuesday.Expedia Group fell 2%,Norwegian Cruise Line Holdings and American Airlines  shares tumbled about 2%.\nBucking the broader market's trend, stay-at-home stock Netflix rose 1.4% and Tesla gained 1.5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848993021,"gmtCreate":1635951706763,"gmtModify":1635951706956,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Provided great insight.","listText":"Provided great insight.","text":"Provided great insight.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848993021","repostId":"843742436","repostType":1,"repost":{"id":843742436,"gmtCreate":1635860881736,"gmtModify":1636561872975,"author":{"id":"3527667588142897","authorId":"3527667588142897","name":"小虎产品经理","avatar":"https://static.tigerbbs.com/a6704bebf28358e0d9c638e765403bd0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Tiger Trade 7.1.2版本来袭，说说你最喜欢哪个功能？","htmlText":"一、版本重要更新 期权榜单增加总成交量，总未平仓量榜单 分时图增加盘前盘后行情展示 社区Tab改版，热门精华内容更易发现 二、主要更新优化详解 1.期权榜单增加总成交量，总未平仓量榜单 热门期权交易股票，发现市场机会 榜单增加：总成交量榜单、总未平仓数榜单 入口可从行情 - 美股Tab进入 2.分时图增加盘前盘后行情展示 个股行情分时图，增加了盘前盘后的分时走势，便于更加直观看到盘前盘中和盘后的走势变化和联系。 点击分时按钮，可以唤起盘前/盘后/全天的分时图切换 3.社区Tab改版，热门精华内容更易发现 社区热门精华一目了然，更快看到你感兴趣的内容 老虎热榜排行展示更加简洁直观 帖子显示相关股票行情，让你更快了解市场动态 原先的直播、学院等Tab大家也可以从顶部Tab进入，空间站和主题的相关入口可以在列表中下滑找到。 小虎君想问问大家 你最喜欢哪个功能？ 你最期待哪个功能可以优化？ 欢迎大家在评论区留言直接发表您对新版本内容的看法和建议，也可以在“我的”-“帮助中心”-“功能反馈”中留下您的意见与反馈，每一条您宝贵的回复都会帮助我们更好的进步。","listText":"一、版本重要更新 期权榜单增加总成交量，总未平仓量榜单 分时图增加盘前盘后行情展示 社区Tab改版，热门精华内容更易发现 二、主要更新优化详解 1.期权榜单增加总成交量，总未平仓量榜单 热门期权交易股票，发现市场机会 榜单增加：总成交量榜单、总未平仓数榜单 入口可从行情 - 美股Tab进入 2.分时图增加盘前盘后行情展示 个股行情分时图，增加了盘前盘后的分时走势，便于更加直观看到盘前盘中和盘后的走势变化和联系。 点击分时按钮，可以唤起盘前/盘后/全天的分时图切换 3.社区Tab改版，热门精华内容更易发现 社区热门精华一目了然，更快看到你感兴趣的内容 老虎热榜排行展示更加简洁直观 帖子显示相关股票行情，让你更快了解市场动态 原先的直播、学院等Tab大家也可以从顶部Tab进入，空间站和主题的相关入口可以在列表中下滑找到。 小虎君想问问大家 你最喜欢哪个功能？ 你最期待哪个功能可以优化？ 欢迎大家在评论区留言直接发表您对新版本内容的看法和建议，也可以在“我的”-“帮助中心”-“功能反馈”中留下您的意见与反馈，每一条您宝贵的回复都会帮助我们更好的进步。","text":"一、版本重要更新 期权榜单增加总成交量，总未平仓量榜单 分时图增加盘前盘后行情展示 社区Tab改版，热门精华内容更易发现 二、主要更新优化详解 1.期权榜单增加总成交量，总未平仓量榜单 热门期权交易股票，发现市场机会 榜单增加：总成交量榜单、总未平仓数榜单 入口可从行情 - 美股Tab进入 2.分时图增加盘前盘后行情展示 个股行情分时图，增加了盘前盘后的分时走势，便于更加直观看到盘前盘中和盘后的走势变化和联系。 点击分时按钮，可以唤起盘前/盘后/全天的分时图切换 3.社区Tab改版，热门精华内容更易发现 社区热门精华一目了然，更快看到你感兴趣的内容 老虎热榜排行展示更加简洁直观 帖子显示相关股票行情，让你更快了解市场动态 原先的直播、学院等Tab大家也可以从顶部Tab进入，空间站和主题的相关入口可以在列表中下滑找到。 小虎君想问问大家 你最喜欢哪个功能？ 你最期待哪个功能可以优化？ 欢迎大家在评论区留言直接发表您对新版本内容的看法和建议，也可以在“我的”-“帮助中心”-“功能反馈”中留下您的意见与反馈，每一条您宝贵的回复都会帮助我们更好的进步。","images":[{"img":"https://static.tigerbbs.com/9698f8aed766f61fc0448bf6f8e12186","width":"688","height":"1489"},{"img":"https://static.tigerbbs.com/62fe78ece5dab1d564316fc3808b6be5","width":"592","height":"1280"},{"img":"https://static.tigerbbs.com/ad21beb20ded24c9adff7a622bb34ed5","width":"688","height":"1529"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843742436","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854329361,"gmtCreate":1635421280994,"gmtModify":1635421319589,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"$20.50Awaiting for financial results to push into $20. Healthy balance sheet and $0.50 dividend next May would be enticing to keep for the next 6 mths.","listText":"$20.50Awaiting for financial results to push into $20. Healthy balance sheet and $0.50 dividend next May would be enticing to keep for the next 6 mths.","text":"$20.50Awaiting for financial results to push into $20. Healthy balance sheet and $0.50 dividend next May would be enticing to keep for the next 6 mths.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854329361","isVote":1,"tweetType":1,"viewCount":510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":609267310,"gmtCreate":1638286937173,"gmtModify":1638286937173,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Short term gain","listText":"Short term gain","text":"Short term gain","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609267310","repostId":"1190156196","repostType":4,"repost":{"id":"1190156196","pubTimestamp":1638242388,"share":"https://www.laohu8.com/m/news/1190156196?lang=&edition=full","pubTime":"2021-11-30 11:19","market":"us","language":"en","title":"5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190156196","media":"InvestorPlace","summary":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race","content":"<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/537aabc5fd6c7ca4f614ce1b37dc0a75\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Shutterstock</span></p>\n<p>As Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?</p>\n<p>Investors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.</p>\n<p>While&nbsp;<b>Pfizer’s</b>(NYSE:<b><u>PFE</u></b>)&nbsp;success in&nbsp;producing&nbsp;a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.</p>\n<p>Many vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.</p>\n<ul>\n <li><b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>)</li>\n <li><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>)</li>\n <li><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>)</li>\n <li><b>Johnson &amp; Johnson</b>(NYSE:<b><u>JNJ</u></b>)</li>\n <li><b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>)</li>\n</ul>\n<p><b>Moderna (MRNA)</b></p>\n<p>Moderna was one of the first companies to have its executive team discuss address the omicron variant.</p>\n<p>On Sunday, CMO Paul Burton spoke to<i>BBC’s</i>Andrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketo<i>CNBC’s</i>“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.</p>\n<p>Bancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.</p>\n<p>This talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.</p>\n<p>While&nbsp;the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p>\n<p>\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times&nbsp;in an interview.</p>\n<p>\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"</p>\n<p><b>Pfizer (PFE)</b></p>\n<p>No pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one&nbsp;<i>InvestorPlace</i>&nbsp;contributorfor CEO of the year.</p>\n<p>The industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.</p>\n<p>Clinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.</p>\n<p>While Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.</p>\n<p>It is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.</p>\n<p><b>BioNTech (BNTX)</b></p>\n<p>Pfizer’s original vaccine partner isn’t missing a beat, either.</p>\n<p>The German biotech innovatortold<i>Business Insider</i>that it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.</p>\n<p>Like its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.</p>\n<p>Like other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,<i>InvestorPlace</i>&nbsp;analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.</p>\n<p><b>Johnson &amp; Johnson (JNJ)</b></p>\n<p>Like its competitors, Johnson &amp; Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”</p>\n<p>Mathai Mammen, global head of research and development at J&amp;J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.</p>\n<p>Mammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.</p>\n<p><b>Novavax (NVAX)</b></p>\n<p>A later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.</p>\n<p>However, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”</p>\n<p>While Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.</p>\n<p>As&nbsp;<i>InvestorPlace</i>&nbsp;Assistant News Writer&nbsp;Eddie Pan&nbsp;reported&nbsp;this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis ...</p>\n\n<a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","JNJ":"强生"},"source_url":"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190156196","content_text":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?\nInvestors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.\nWhile Pfizer’s(NYSE:PFE) success in producing a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.\nMany vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.\n\nModerna(NASDAQ:MRNA)\nPfizer(NYSE:PFE)\nBioNTech (NASDAQ:BNTX)\nJohnson & Johnson(NYSE:JNJ)\nNovavax(NASDAQ:NVAX)\n\nModerna (MRNA)\nModerna was one of the first companies to have its executive team discuss address the omicron variant.\nOn Sunday, CMO Paul Burton spoke toBBC’sAndrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketoCNBC’s“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.\nBancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.\nThis talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.\nWhile the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nPfizer (PFE)\nNo pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one InvestorPlace contributorfor CEO of the year.\nThe industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.\nClinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.\nWhile Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.\nIt is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.\nBioNTech (BNTX)\nPfizer’s original vaccine partner isn’t missing a beat, either.\nThe German biotech innovatortoldBusiness Insiderthat it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.\nLike its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.\nLike other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,InvestorPlace analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.\nJohnson & Johnson (JNJ)\nLike its competitors, Johnson & Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”\nMathai Mammen, global head of research and development at J&J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.\nMammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.\nNovavax (NVAX)\nA later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.\nHowever, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”\nWhile Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.\nAs InvestorPlace Assistant News Writer Eddie Pan reported this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602622932,"gmtCreate":1639017160657,"gmtModify":1639017160657,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keep it coming","listText":"Keep it coming","text":"Keep it coming","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602622932","repostId":"2190169579","repostType":4,"repost":{"id":"2190169579","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639001174,"share":"https://www.laohu8.com/m/news/2190169579?lang=&edition=full","pubTime":"2021-12-09 06:06","market":"us","language":"en","title":"Wall St closes higher as vaccine update feeds optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2190169579","media":"Reuters","summary":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st","content":"<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes higher as vaccine update feeds optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes higher as vaccine update feeds optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 06:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","TQQQ":"纳指三倍做多ETF","SWK":"美国史丹利公司","PFE":"辉瑞","BK4007":"制药","BK4566":"资本集团","SQQQ":"纳指三倍做空ETF","DXD":"道指两倍做空ETF","NCLH":"挪威邮轮","PSQ":"纳指反向ETF","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓",".DJI":"道琼斯","BK4517":"邮轮概念",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","QID":"纳指两倍做空ETF","CCL":"嘉年华邮轮","DDM":"道指两倍做多ETF","BK4142":"酒店、度假村与豪华游轮","QQQ":"纳指100ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","UDOW":"道指三倍做多ETF-ProShares","SDOW":"道指三倍做空ETF-ProShares","QLD":"纳指两倍做多ETF","BK4161":"工业机械","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190169579","content_text":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.\nPfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.\nInvestors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.\nMarkets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.\nIn a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.\nWhile Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.\nWith Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"\n\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.\nThe Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.\nThe S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.\n\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.\nSector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.\nWHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.\nSo-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.\nGoodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".\nStanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.\nOn U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":754,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609264096,"gmtCreate":1638286871807,"gmtModify":1638286871807,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609264096","repostId":"2187817235","repostType":4,"repost":{"id":"2187817235","pubTimestamp":1638279553,"share":"https://www.laohu8.com/m/news/2187817235?lang=&edition=full","pubTime":"2021-11-30 21:39","market":"us","language":"en","title":"4 Stocks Billionaires Are Buying Hand Over Fist","url":"https://stock-news.laohu8.com/highlight/detail?id=2187817235","media":"Motley Fool","summary":"Successful money managers purchased a number of unexpected stocks in the third quarter.","content":"<p>You may not realize it, but one of the most important data releases of the quarter occurred approximately two weeks ago.</p>\n<p>On Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). A 13F provides Wall Street and investors with an under-the-hood look at what the smartest money managers were buying and selling in the previous quarter (i.e., the third quarter). Though 13Fs are a bit dated by the time they're filed with the SEC (holdings are as of Sept. 30, 2021), they still provide valuable clues of what's catching the attention of the world's most successful fund managers.</p>\n<p>With the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. However, they didn't necessarily buy the names you'd expect.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F654909%2Fbusinessman-looking-at-ticker-board-stock-market-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Ken Griffin (Citadel Advisors): Tesla Motors</h2>\n<p>Billionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions. But the big story from the third quarter is that Citadel made electric vehicle (EV) manufacturer <b>Tesla Motors</b> (NASDAQ:TSLA) its largest non-options holding. Griffin's fund bought close to 1.8 million shares of Tesla in the third quarter, increasing its position by 873% from the end of June.</p>\n<p>Why Tesla? One logical explanation is that EVs are inevitable. Pretty much every major economic powerhouse worldwide is focused on reducing carbon emissions going forward. Perhaps the easiest way to make a dent in carbon emissions is to push a multi-decade vehicle replacement cycle.</p>\n<p>A more likely explanation for Griffin's interest in Tesla is the company's first-mover advantage. Even with an ongoing semiconductor chip shortage, Tesla looks to be on pace to hit 800,000 (or more) EV deliveries in 2021. Further, it could reasonably pace 50% annual delivery growth over the next couple of years as new gigafactories come online. With no other automakers coming close (at the moment) to its combination of battery range, power, and capacity, Griffin likely feels he and his fund can ride this momentum higher.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F654909%2Fko-drink-bottle.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"><span>Image source: Coca-Cola.</span></p>\n<h2>Jim Simons (Renaissance Technologies): Coca-Cola</h2>\n<p>For a highly diversified fund known for its love of innovation, the shock of the quarter might just be that billionaire Jim Simons was buying beverage giant <b>Coca-Cola</b> (NYSE:KO) hand over fist. All told, Renaissance Technologies added a little over 6 million shares of Coke in the third quarter, which more than tripled its stake as of the end of June.</p>\n<p>With the benchmark <b>S&amp;P 500</b> taking less than 17 months to double from its coronavirus bear-market bottom, Simons' substantially increased stake in Coke might be a means of playing it safe and hedging his funds' bets. Since Coca-Cola has a presence in all but two countries worldwide (Cuba and North Korea), and its portfolio sports more than 20 brands generating at least $1 billion in annual sales, it's a safe bet to generate modest returns -- or at worst hold up much better than the broader market if a crash or correction strikes.</p>\n<p>Coca-Cola is also a relatively smart inflation play. The company is parsing out a hearty 3.1% yield, has raised its base annual dividend for 59 consecutive years, and its well-known brand makes it easy for the company to pass along higher costs to its customers.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F654909%2Fmature-woman-shopping-mall-retail-gdp-clothing-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>David Tepper (Appaloosa): Macy's</h2>\n<p>In a market dominated by growth stocks, billionaire David Tepper headed to the retail counter in the third quarter and piled into department store <b>Macy's</b> (NYSE:M). Tepper's Appaloosa purchased 3.39 million shares, which lifted the fund's stake to an even 7 million shares.</p>\n<p>Scratching your head as to why a successful money manager is buying into an old-school retailer? The answer looks to be Macy's, thus far, solid execution on its three-year Polaris strategy. In no particular order, this strategy includes:</p>\n<ul>\n <li>Closing underperforming stores and reducing corporate and store-level staff to cut expenses.</li>\n <li>Emphasizing digital sales channels, which are a high-growth opportunity for the company until the pandemic ends (and perhaps well after).</li>\n <li>Increasing customer engagement through its loyalty rewards program.</li>\n <li>Focusing its efforts of a small number of higher-margin private brands.</li>\n</ul>\n<p>Although Macy's has challenges to overcome, such as continuing to pay down more than $6 billion in debt, the initial results show its digitization and branding efforts are paying off. The company ended September with 4.4 million new customers, up 28% from the comparable period in 2019 (i.e., before the pandemic). Additionally, 33% of net sales derived online, up from 23% in Q3 2019.&nbsp; If these arrows continue to point higher, Tepper may have found himself a bargain.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F654909%2Fwoman-talk-smartphone-city-wireless-5g-4g-data-voicemail-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Israel Englander (Millennium Management): AT&amp;T</h2>\n<p>Like Ken Griffin, billionaire Israel Englander is a big fan of utilizing put and call options to maximize returns for his fund, Millennium Management. However, the big buy in the third quarter was stodgy telecom giant <b>AT&amp;T</b> (NYSE:T). Englander's fund bought up close to 11.2 million shares, which increased its stake by 165% from the sequential second quarter.</p>\n<p>Similar to Coca-Cola, buying AT&amp;T is a play on value and stability in a very pricey market. For the time being, it's paying out an inflation-topping 8.6% yield and can be purchased for a little north of 7 times Wall Street's estimated earnings per share this year.</p>\n<p>But what might have wet Englander's whistle is AT&amp;T's plan to spin off its content arm, WarnerMedia, and combine it with <b>Discovery</b>. Combining forces will save more than $3 billion in annual costs and vastly improve original and sports programming options for streaming customers. Most importantly, it'll allow AT&amp;T to reduce its debt (and its dividend, as well) and focus on growing its wireless business with the ongoing rollout of 5G infrastructure.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Billionaires Are Buying Hand Over Fist</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Billionaires Are Buying Hand Over Fist\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/30/4-stocks-billionaires-are-buying-hand-over-fist/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You may not realize it, but one of the most important data releases of the quarter occurred approximately two weeks ago.\nOn Nov. 15, institutional investors and hedge funds with at least $100 million ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/30/4-stocks-billionaires-are-buying-hand-over-fist/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","BK4548":"巴美列捷福持仓","EV":"MAST GLOBAL BATTERY RECYCLING & PRODUCTION ETF","T":"美国电话电报","KO":"可口可乐","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4177":"软饮料","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","M":"梅西百货","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","BK4115":"综合电信业务","BK4551":"寇图资本持仓","BK4103":"百货商店","BK4504":"桥水持仓","BK4099":"汽车制造商"},"source_url":"https://www.fool.com/investing/2021/11/30/4-stocks-billionaires-are-buying-hand-over-fist/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187817235","content_text":"You may not realize it, but one of the most important data releases of the quarter occurred approximately two weeks ago.\nOn Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). A 13F provides Wall Street and investors with an under-the-hood look at what the smartest money managers were buying and selling in the previous quarter (i.e., the third quarter). Though 13Fs are a bit dated by the time they're filed with the SEC (holdings are as of Sept. 30, 2021), they still provide valuable clues of what's catching the attention of the world's most successful fund managers.\nWith the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. However, they didn't necessarily buy the names you'd expect.\nImage source: Getty Images.\nKen Griffin (Citadel Advisors): Tesla Motors\nBillionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions. But the big story from the third quarter is that Citadel made electric vehicle (EV) manufacturer Tesla Motors (NASDAQ:TSLA) its largest non-options holding. Griffin's fund bought close to 1.8 million shares of Tesla in the third quarter, increasing its position by 873% from the end of June.\nWhy Tesla? One logical explanation is that EVs are inevitable. Pretty much every major economic powerhouse worldwide is focused on reducing carbon emissions going forward. Perhaps the easiest way to make a dent in carbon emissions is to push a multi-decade vehicle replacement cycle.\nA more likely explanation for Griffin's interest in Tesla is the company's first-mover advantage. Even with an ongoing semiconductor chip shortage, Tesla looks to be on pace to hit 800,000 (or more) EV deliveries in 2021. Further, it could reasonably pace 50% annual delivery growth over the next couple of years as new gigafactories come online. With no other automakers coming close (at the moment) to its combination of battery range, power, and capacity, Griffin likely feels he and his fund can ride this momentum higher.\nImage source: Coca-Cola.\nJim Simons (Renaissance Technologies): Coca-Cola\nFor a highly diversified fund known for its love of innovation, the shock of the quarter might just be that billionaire Jim Simons was buying beverage giant Coca-Cola (NYSE:KO) hand over fist. All told, Renaissance Technologies added a little over 6 million shares of Coke in the third quarter, which more than tripled its stake as of the end of June.\nWith the benchmark S&P 500 taking less than 17 months to double from its coronavirus bear-market bottom, Simons' substantially increased stake in Coke might be a means of playing it safe and hedging his funds' bets. Since Coca-Cola has a presence in all but two countries worldwide (Cuba and North Korea), and its portfolio sports more than 20 brands generating at least $1 billion in annual sales, it's a safe bet to generate modest returns -- or at worst hold up much better than the broader market if a crash or correction strikes.\nCoca-Cola is also a relatively smart inflation play. The company is parsing out a hearty 3.1% yield, has raised its base annual dividend for 59 consecutive years, and its well-known brand makes it easy for the company to pass along higher costs to its customers.\nImage source: Getty Images.\nDavid Tepper (Appaloosa): Macy's\nIn a market dominated by growth stocks, billionaire David Tepper headed to the retail counter in the third quarter and piled into department store Macy's (NYSE:M). Tepper's Appaloosa purchased 3.39 million shares, which lifted the fund's stake to an even 7 million shares.\nScratching your head as to why a successful money manager is buying into an old-school retailer? The answer looks to be Macy's, thus far, solid execution on its three-year Polaris strategy. In no particular order, this strategy includes:\n\nClosing underperforming stores and reducing corporate and store-level staff to cut expenses.\nEmphasizing digital sales channels, which are a high-growth opportunity for the company until the pandemic ends (and perhaps well after).\nIncreasing customer engagement through its loyalty rewards program.\nFocusing its efforts of a small number of higher-margin private brands.\n\nAlthough Macy's has challenges to overcome, such as continuing to pay down more than $6 billion in debt, the initial results show its digitization and branding efforts are paying off. The company ended September with 4.4 million new customers, up 28% from the comparable period in 2019 (i.e., before the pandemic). Additionally, 33% of net sales derived online, up from 23% in Q3 2019.  If these arrows continue to point higher, Tepper may have found himself a bargain.\nImage source: Getty Images.\nIsrael Englander (Millennium Management): AT&T\nLike Ken Griffin, billionaire Israel Englander is a big fan of utilizing put and call options to maximize returns for his fund, Millennium Management. However, the big buy in the third quarter was stodgy telecom giant AT&T (NYSE:T). Englander's fund bought up close to 11.2 million shares, which increased its stake by 165% from the sequential second quarter.\nSimilar to Coca-Cola, buying AT&T is a play on value and stability in a very pricey market. For the time being, it's paying out an inflation-topping 8.6% yield and can be purchased for a little north of 7 times Wall Street's estimated earnings per share this year.\nBut what might have wet Englander's whistle is AT&T's plan to spin off its content arm, WarnerMedia, and combine it with Discovery. Combining forces will save more than $3 billion in annual costs and vastly improve original and sports programming options for streaming customers. Most importantly, it'll allow AT&T to reduce its debt (and its dividend, as well) and focus on growing its wireless business with the ongoing rollout of 5G infrastructure.","news_type":1},"isVote":1,"tweetType":1,"viewCount":571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696936634,"gmtCreate":1640594414920,"gmtModify":1640594414992,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696936634","repostId":"2194177239","repostType":4,"repost":{"id":"2194177239","pubTimestamp":1640559609,"share":"https://www.laohu8.com/m/news/2194177239?lang=&edition=full","pubTime":"2021-12-27 07:00","market":"us","language":"en","title":"Santa Claus Rally watch: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177239","media":"Yahoo Finance","summary":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.The S&P 500  is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any ","content":"<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.</p>\n<p>The S&amp;P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.</p>\n<p>The term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.</p>\n<p>According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&amp;P 500 78.9% of the time, with an average return of 1.33%.</p>\n<p>“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”</p>\n<p>And if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.</p>\n<p>\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.</p>\n<p>“Considering the bear markets of 2000 and 2008 both took place after <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"</p>\n<p>And this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.</p>\n<p>\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1279eeacff5d764e6ff5b3e8f7a24f49\" tg-width=\"4000\" tg-height=\"2667\" referrerpolicy=\"no-referrer\"><span>A man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images</span></p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b>Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)</p></li>\n <li><p><b>Tuesday: </b>FHFA House Price Index, month-over-month, October (0.9% in September); S&amp;P <a href=\"https://laohu8.com/S/CLGX\">CoreLogic</a> Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&amp;P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&amp;P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)</p></li>\n <li><p><b>Wednesday: </b>Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)</p></li>\n <li><p><b>Thursday: </b>Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)</p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Wednesday: </b>FuelCell Energy Inc. (FCEL) before market open</p></li>\n <li><p><b>Thursday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Santa Claus Rally watch: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanta Claus Rally watch: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 07:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p>\n\n<a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4541":"氢能源","SPY.AU":"SPDR® S&P 500® ETF Trust","BK4096":"电气部件与设备","FCEL":"燃料电池能源"},"source_url":"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177239","content_text":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.\nThe S&P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.\nThe term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.\nAccording to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&P 500 78.9% of the time, with an average return of 1.33%.\n“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”\nAnd if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.\n\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.\n“Considering the bear markets of 2000 and 2008 both took place after one of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"\nAnd this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.\n\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"\nA man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images\nEconomic calendar\n\nMonday: Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)\nTuesday: FHFA House Price Index, month-over-month, October (0.9% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)\nWednesday: Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)\nThursday: Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)\nFriday: No notable reports scheduled for release\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: FuelCell Energy Inc. (FCEL) before market open\nThursday: No notable reports scheduled for release\nFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691353331,"gmtCreate":1640140258317,"gmtModify":1640140258403,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Alright","listText":"Alright","text":"Alright","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691353331","repostId":"2193663561","repostType":4,"repost":{"id":"2193663561","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640125936,"share":"https://www.laohu8.com/m/news/2193663561?lang=&edition=full","pubTime":"2021-12-22 06:32","market":"us","language":"en","title":"Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2193663561","media":"Reuters","summary":"Dec 21  - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.Gains in massive technology and tech-related stock","content":"<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes up strongly with boost from Nike, Micron, following Omicron slide\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-22 06:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MU":"美光科技","SQQQ":"纳指三倍做空ETF","PSQ":"纳指反向ETF","DXD":"道指两倍做空ETF","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4146":"鞋类","BK4558":"双十一","BK4566":"资本集团","QID":"纳指两倍做空ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","NKE":"耐克","DDM":"道指两倍做多ETF","UDOW":"道指三倍做多ETF-ProShares","BK4561":"索罗斯持仓","SDOW":"道指三倍做空ETF-ProShares","DOG":"道指反向ETF","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","DJX":"1/100道琼斯","TQQQ":"纳指三倍做多ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193663561","content_text":"Energy, tech top-gaining S&P 500 sectors\nTravel stocks surge broadly\nNike up after beating quarterly estimates\nMicron rises as it sees chip shortages easing\nIndexes up: Dow 1.6%, S&P 1.78%, Nasdaq 2.4%\n\nDec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.\nThe rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.\nGains in massive technology and tech-related stocks such as Microsoft and Amazon lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands and Expedia Group.\n“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”\nThe Dow Jones Industrial Average rose 560.54 points, or 1.6%, to 35,492.7, the S&P 500 gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite added 360.14 points, or 2.4%, to 15,341.09.\nDefensive sectors, such as consumer staples and utilities that have led in December, lagged on Tuesday.\nNike shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.\nMicron Technology shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index rose 3.4%.\n“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"\nGeneral Mills shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.\nThe benchmark S&P 500 has gained 23.8% so far in 2021.\nSome investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.\n\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.\nThe S&P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.\nAbout 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607081466,"gmtCreate":1639457813749,"gmtModify":1639457813749,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607081466","repostId":"2191841329","repostType":4,"repost":{"id":"2191841329","pubTimestamp":1639452680,"share":"https://www.laohu8.com/m/news/2191841329?lang=&edition=full","pubTime":"2021-12-14 11:31","market":"us","language":"en","title":"Highly valued S&P 500 index is 'near the top of its 85-year trend channel,' says Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2191841329","media":"MarketWatch","summary":"'Inflation has historically been neutral for earnings, but negative for multiples,' says a Deutsche ","content":"<p>'Inflation has historically been neutral for earnings, but negative for multiples,' says a Deutsche Bank report</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7b7803ce34d9ebaddbf2c083be3d67a2\" tg-width=\"700\" tg-height=\"458\" referrerpolicy=\"no-referrer\"><span>The S&amp;P 500 index closed at a record high on Dec. 10, 2021. Chris Hondros/Getty Images</span></p>\n<p>The S&amp;P 500's \"extremely high\" historical valuation puts the index near the upper bound of a \"trend channel of price appreciation\" that spans more than eight decades, but the broad equity benchmark still could go higher, according to Deutsche Bank Research.</p>\n<p>The U.S. stock index is \"near the top of its 85-year trend channel,\" the bank's strategists wrote in a research report dated Dec. 10. \"It was only higher in the late 1930s and late 1990s, when it went above,\" a chart in the report shows.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4d4fc2a69934ea51cf28c489fdfd23d4\" tg-width=\"700\" tg-height=\"423\" referrerpolicy=\"no-referrer\"><span>DEUTSCHE BANK RESEARCH REPORT DATED DEC. 10, 2021</span></p>\n<p>The S&amp;P 500 closed Dec. 10 at a record high of 4,712.02 and is on track to gain more than 24% this year, according to FactSet data.</p>\n<p>Deutsche Bank's strategists project the index will continue to climb next year, pointing to earnings growth and saying in their report that stock buybacks should help keep S&amp;P 500 returns strong, particularly in the first half of 2022. They have a price target of 5,250 for the S&amp;P 500 by the end of next year, according to their research note.</p>\n<p>Deutsche Bank Research is part of the investment banking division. Separately, the chief investment office of the bank's wealth-management division provided a 2022 outlook presentation on Dec. 6 that showed an S&amp;P 500 target of 5,000.</p>\n<p>\"For the S&amp;P 500, we see 10% earnings growth to $230 in 2022,\" according to the Deutsche Bank Research note dated Dec. 10, with the strategists referring to their earnings-per-share forecast.</p>\n<p>\"Inflation has historically been neutral for earnings, but negative for multiples,\" they wrote, against the backdrop of a surge in the cost of living during the pandemic.</p>\n<p>Valuations for the S&amp;P 500 index are \"extremely high,\" according to the Deutsche Bank Research report. \"Equity valuations are in the 97-100th percentile on almost any metric excluding the 1990s tech bubble period and well into the 90s in percentile terms even including it,\" the strategists wrote.</p>\n<p>Their 2022 forecast for the S&amp;P 500 implies a trailing 12-month price-to earnings ratio of 22.8, the research report from Dec. 10 shows.</p>\n<p>\"With earnings having already recovered to levels above trend that often marked cycle peaks and equity valuations historically high, the outlook for equities looks subject to a larger degree of uncertainty and a wider range of possible outcomes than is typical,\" the strategists cautioned.</p>\n<p>U.S. stock indexes closed lower Monday, with S&amp;P 500 ending 0.9% lower, FactSet data show.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Highly valued S&P 500 index is 'near the top of its 85-year trend channel,' says Deutsche Bank</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHighly valued S&P 500 index is 'near the top of its 85-year trend channel,' says Deutsche Bank\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 11:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/highly-valued-s-p-500-index-is-near-the-top-of-its-85-year-trend-channel-says-deutsche-bank-11639432105?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>'Inflation has historically been neutral for earnings, but negative for multiples,' says a Deutsche Bank report\nThe S&P 500 index closed at a record high on Dec. 10, 2021. Chris Hondros/Getty Images\n...</p>\n\n<a href=\"https://www.marketwatch.com/story/highly-valued-s-p-500-index-is-near-the-top-of-its-85-year-trend-channel-says-deutsche-bank-11639432105?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","OEX":"标普100","SSO":"两倍做多标普500ETF","BK4534":"瑞士信贷持仓","SPXU":"三倍做空标普500ETF","BK4566":"资本集团","OEF":"标普100指数ETF-iShares","SPY":"标普500ETF","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","DB":"德意志银行",".IXIC":"NASDAQ Composite","BK4552":"Archegos爆仓风波概念","BK4118":"综合性资本市场","IVV":"标普500指数ETF","UPRO":"三倍做多标普500ETF","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF",".DJI":"道琼斯","SH":"标普500反向ETF"},"source_url":"https://www.marketwatch.com/story/highly-valued-s-p-500-index-is-near-the-top-of-its-85-year-trend-channel-says-deutsche-bank-11639432105?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191841329","content_text":"'Inflation has historically been neutral for earnings, but negative for multiples,' says a Deutsche Bank report\nThe S&P 500 index closed at a record high on Dec. 10, 2021. Chris Hondros/Getty Images\nThe S&P 500's \"extremely high\" historical valuation puts the index near the upper bound of a \"trend channel of price appreciation\" that spans more than eight decades, but the broad equity benchmark still could go higher, according to Deutsche Bank Research.\nThe U.S. stock index is \"near the top of its 85-year trend channel,\" the bank's strategists wrote in a research report dated Dec. 10. \"It was only higher in the late 1930s and late 1990s, when it went above,\" a chart in the report shows.\nDEUTSCHE BANK RESEARCH REPORT DATED DEC. 10, 2021\nThe S&P 500 closed Dec. 10 at a record high of 4,712.02 and is on track to gain more than 24% this year, according to FactSet data.\nDeutsche Bank's strategists project the index will continue to climb next year, pointing to earnings growth and saying in their report that stock buybacks should help keep S&P 500 returns strong, particularly in the first half of 2022. They have a price target of 5,250 for the S&P 500 by the end of next year, according to their research note.\nDeutsche Bank Research is part of the investment banking division. Separately, the chief investment office of the bank's wealth-management division provided a 2022 outlook presentation on Dec. 6 that showed an S&P 500 target of 5,000.\n\"For the S&P 500, we see 10% earnings growth to $230 in 2022,\" according to the Deutsche Bank Research note dated Dec. 10, with the strategists referring to their earnings-per-share forecast.\n\"Inflation has historically been neutral for earnings, but negative for multiples,\" they wrote, against the backdrop of a surge in the cost of living during the pandemic.\nValuations for the S&P 500 index are \"extremely high,\" according to the Deutsche Bank Research report. \"Equity valuations are in the 97-100th percentile on almost any metric excluding the 1990s tech bubble period and well into the 90s in percentile terms even including it,\" the strategists wrote.\nTheir 2022 forecast for the S&P 500 implies a trailing 12-month price-to earnings ratio of 22.8, the research report from Dec. 10 shows.\n\"With earnings having already recovered to levels above trend that often marked cycle peaks and equity valuations historically high, the outlook for equities looks subject to a larger degree of uncertainty and a wider range of possible outcomes than is typical,\" the strategists cautioned.\nU.S. stock indexes closed lower Monday, with S&P 500 ending 0.9% lower, FactSet data show.","news_type":1},"isVote":1,"tweetType":1,"viewCount":689,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607088733,"gmtCreate":1639457971423,"gmtModify":1639458111886,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607088733","repostId":"1174933722","repostType":4,"isVote":1,"tweetType":1,"viewCount":502,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602628726,"gmtCreate":1639017058007,"gmtModify":1639017058077,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Agree","listText":"Agree","text":"Agree","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602628726","repostId":"2190169579","repostType":4,"repost":{"id":"2190169579","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639001174,"share":"https://www.laohu8.com/m/news/2190169579?lang=&edition=full","pubTime":"2021-12-09 06:06","market":"us","language":"en","title":"Wall St closes higher as vaccine update feeds optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2190169579","media":"Reuters","summary":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st","content":"<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes higher as vaccine update feeds optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes higher as vaccine update feeds optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 06:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.</p>\n<p>Pfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.</p>\n<p>Investors reacted by piling into travel related stocks. The S&amp;P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.</p>\n<p>Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.</p>\n<p>In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.</p>\n<p>While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.</p>\n<p>With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"</p>\n<p>\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.</p>\n<p>The Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&amp;P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.</p>\n<p>The S&amp;P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.</p>\n<p>\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.</p>\n<p>Sector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&amp;P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.</p>\n<p>WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.</p>\n<p>So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&amp;P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.</p>\n<p>Goodyear Tire &amp; Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".</p>\n<p>Stanley Black &amp; Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.</p>\n<p>On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","TQQQ":"纳指三倍做多ETF","SWK":"美国史丹利公司","PFE":"辉瑞","BK4007":"制药","BK4566":"资本集团","SQQQ":"纳指三倍做空ETF","DXD":"道指两倍做空ETF","NCLH":"挪威邮轮","PSQ":"纳指反向ETF","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓",".DJI":"道琼斯","BK4517":"邮轮概念",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","QID":"纳指两倍做空ETF","CCL":"嘉年华邮轮","DDM":"道指两倍做多ETF","BK4142":"酒店、度假村与豪华游轮","QQQ":"纳指100ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","UDOW":"道指三倍做多ETF-ProShares","SDOW":"道指三倍做空ETF-ProShares","QLD":"纳指两倍做多ETF","BK4161":"工业机械","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190169579","content_text":"Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.\nPfizer and BioNTech said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.\nInvestors reacted by piling into travel related stocks. The S&P 1500 Airlines index closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.\nMarkets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.\nIn a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.\nWhile Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.\nWith Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a \"perfect risk-on kind of day.\"\n\"A lot is revolving around virus news. It's a reopening trade more than anything else,\" said Nolte.\nThe Dow Jones Industrial Average rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite added 100.07 points, or 0.64%, to 15,786.99.\nThe S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.\n\"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals,\" said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.\nSector gains were led by communication services, which rose 0.75% followed closely by healthcare , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials , down 0.46%, consumer staples , down 0.37% and utilities , which edged down 0.1%.\nWHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.\nSo-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line, up 8%, Carnival Corp, up 5.5% and Royal Caribbean, up 5.2%.\nGoodyear Tire & Rubber Co rose 2.6% after Deutsche Bank upgraded the stock to \"buy\" from \"hold\".\nStanley Black & Decker advanced 3.3% after Sweden's Securitas agreed to buy its electronic security solutions business for $3.2 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.\nOn U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609672054,"gmtCreate":1638283492985,"gmtModify":1638283492985,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Downtrend","listText":"Downtrend","text":"Downtrend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609672054","repostId":"1167187587","repostType":4,"isVote":1,"tweetType":1,"viewCount":665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848993021,"gmtCreate":1635951706763,"gmtModify":1635951706956,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Provided great insight.","listText":"Provided great insight.","text":"Provided great insight.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848993021","repostId":"843742436","repostType":1,"repost":{"id":843742436,"gmtCreate":1635860881736,"gmtModify":1636561872975,"author":{"id":"3527667588142897","authorId":"3527667588142897","name":"小虎产品经理","avatar":"https://static.tigerbbs.com/a6704bebf28358e0d9c638e765403bd0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Tiger Trade 7.1.2版本来袭，说说你最喜欢哪个功能？","htmlText":"一、版本重要更新 期权榜单增加总成交量，总未平仓量榜单 分时图增加盘前盘后行情展示 社区Tab改版，热门精华内容更易发现 二、主要更新优化详解 1.期权榜单增加总成交量，总未平仓量榜单 热门期权交易股票，发现市场机会 榜单增加：总成交量榜单、总未平仓数榜单 入口可从行情 - 美股Tab进入 2.分时图增加盘前盘后行情展示 个股行情分时图，增加了盘前盘后的分时走势，便于更加直观看到盘前盘中和盘后的走势变化和联系。 点击分时按钮，可以唤起盘前/盘后/全天的分时图切换 3.社区Tab改版，热门精华内容更易发现 社区热门精华一目了然，更快看到你感兴趣的内容 老虎热榜排行展示更加简洁直观 帖子显示相关股票行情，让你更快了解市场动态 原先的直播、学院等Tab大家也可以从顶部Tab进入，空间站和主题的相关入口可以在列表中下滑找到。 小虎君想问问大家 你最喜欢哪个功能？ 你最期待哪个功能可以优化？ 欢迎大家在评论区留言直接发表您对新版本内容的看法和建议，也可以在“我的”-“帮助中心”-“功能反馈”中留下您的意见与反馈，每一条您宝贵的回复都会帮助我们更好的进步。","listText":"一、版本重要更新 期权榜单增加总成交量，总未平仓量榜单 分时图增加盘前盘后行情展示 社区Tab改版，热门精华内容更易发现 二、主要更新优化详解 1.期权榜单增加总成交量，总未平仓量榜单 热门期权交易股票，发现市场机会 榜单增加：总成交量榜单、总未平仓数榜单 入口可从行情 - 美股Tab进入 2.分时图增加盘前盘后行情展示 个股行情分时图，增加了盘前盘后的分时走势，便于更加直观看到盘前盘中和盘后的走势变化和联系。 点击分时按钮，可以唤起盘前/盘后/全天的分时图切换 3.社区Tab改版，热门精华内容更易发现 社区热门精华一目了然，更快看到你感兴趣的内容 老虎热榜排行展示更加简洁直观 帖子显示相关股票行情，让你更快了解市场动态 原先的直播、学院等Tab大家也可以从顶部Tab进入，空间站和主题的相关入口可以在列表中下滑找到。 小虎君想问问大家 你最喜欢哪个功能？ 你最期待哪个功能可以优化？ 欢迎大家在评论区留言直接发表您对新版本内容的看法和建议，也可以在“我的”-“帮助中心”-“功能反馈”中留下您的意见与反馈，每一条您宝贵的回复都会帮助我们更好的进步。","text":"一、版本重要更新 期权榜单增加总成交量，总未平仓量榜单 分时图增加盘前盘后行情展示 社区Tab改版，热门精华内容更易发现 二、主要更新优化详解 1.期权榜单增加总成交量，总未平仓量榜单 热门期权交易股票，发现市场机会 榜单增加：总成交量榜单、总未平仓数榜单 入口可从行情 - 美股Tab进入 2.分时图增加盘前盘后行情展示 个股行情分时图，增加了盘前盘后的分时走势，便于更加直观看到盘前盘中和盘后的走势变化和联系。 点击分时按钮，可以唤起盘前/盘后/全天的分时图切换 3.社区Tab改版，热门精华内容更易发现 社区热门精华一目了然，更快看到你感兴趣的内容 老虎热榜排行展示更加简洁直观 帖子显示相关股票行情，让你更快了解市场动态 原先的直播、学院等Tab大家也可以从顶部Tab进入，空间站和主题的相关入口可以在列表中下滑找到。 小虎君想问问大家 你最喜欢哪个功能？ 你最期待哪个功能可以优化？ 欢迎大家在评论区留言直接发表您对新版本内容的看法和建议，也可以在“我的”-“帮助中心”-“功能反馈”中留下您的意见与反馈，每一条您宝贵的回复都会帮助我们更好的进步。","images":[{"img":"https://static.tigerbbs.com/9698f8aed766f61fc0448bf6f8e12186","width":"688","height":"1489"},{"img":"https://static.tigerbbs.com/62fe78ece5dab1d564316fc3808b6be5","width":"592","height":"1280"},{"img":"https://static.tigerbbs.com/ad21beb20ded24c9adff7a622bb34ed5","width":"688","height":"1529"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843742436","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":5,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854329361,"gmtCreate":1635421280994,"gmtModify":1635421319589,"author":{"id":"3582775076031310","authorId":"3582775076031310","name":"Untame","avatar":"https://static.tigerbbs.com/9b6e9845bbc029072753b4b7df4f25d5","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"$20.50Awaiting for financial results to push into $20. Healthy balance sheet and $0.50 dividend next May would be enticing to keep for the next 6 mths.","listText":"$20.50Awaiting for financial results to push into $20. Healthy balance sheet and $0.50 dividend next May would be enticing to keep for the next 6 mths.","text":"$20.50Awaiting for financial results to push into $20. Healthy balance sheet and $0.50 dividend next May would be enticing to keep for the next 6 mths.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854329361","isVote":1,"tweetType":1,"viewCount":510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}